Wednesday, January 16, 2019
Introducing a new corporate identity and 3 business elements.
Monday, January 7, 2019
Together we move from a solution to solutions.
Wednesday, April 18, 2018
This is an example of a news item behind login

News archive

Wednesday, January 16, 2019
Introducing a new corporate identity and 3 business elements.
Monday, January 7, 2019
Together we move from a solution to solutions.
Wednesday, April 18, 2018
This is an example of a news item behind login
Tuesday, November 28, 2017
New study supports extended beyond use dating in Fagron unit dose syringe
Tuesday, July 18, 2017
Fagron US announces launch Of LETS GEL KIT™ for rapid topical anesthesia
Wednesday, December 21, 2016
Oseltamivir phosphate 6 mg/ml in SyrSpend® SF PH4 is currently compatible for at least 60 days and the study is still running until 90 days.
Wednesday, December 21, 2016
Fagron’s trademark vehicle SyrSpend® SF does not contain any parabens or other unwanted excipients and is therefore suitable for a broad group of patients, including children.
Monday, October 3, 2016
Transdermal Oxandrolone: Ex vivo Percutaneous Absorption Study
Thursday, September 22, 2016
Pharmacists have a vital role in the outcome of pharmacological therapies and ultimately strive to improve patients quality of life.
Tuesday, September 20, 2016
The ban of MI in leave-on products by the EC underlines the importance of ingredient safety.
Thursday, September 8, 2016
Fagron is very happy to announce that we have launched the class I registered medical device Nourisil™ MD
Monday, August 8, 2016
Fagron Brazil, Fagron Technologies, Pharma Nostra, Florien and Via Farma have all exhibited at Consulfarma 2016
Wednesday, July 20, 2016
Fagron Belgium received many positive reactions on the atopic schools initiative and FAD products.
Tuesday, June 28, 2016
Fagron is happy to announce that SyrSpend® SF is currently being recognized by large pharmaceutical companies for its quality and compatibility, as is demonstrated by the fact that two big pharmaceutical companies are using the product for their clinical
Monday, May 2, 2016
The European Commission (EC) announced the public consultation on methylisothiazolinone (MI) in rinse-off cosmetic products proposing a restriction of its use and a ban for the use in leave-on products.
Friday, April 22, 2016
Fagron was invited to speak at the 39th annual congress of the European Pharmaceutical Students Association (EPSA) in Helsinki, Finland.
Tuesday, April 5, 2016
In the study published in the April edition of Die Pharmazie, the physical and chemical stability of another 10 APIs was studied in SyrSpend® SF PH4 liquid
Tuesday, March 29, 2016
SyrSpend® SF is a unique ready-to-use suspending vehicle that has been gaining momentum in compounding pharmacies worldwide.
Monday, March 21, 2016
Influenza is a major health problem that can result in hospitalization
Thursday, March 3, 2016
For the 21st time the European Association of Hospital Pharmacists (EAHP) organizes the largest annual congress on hospital pharmacy in Europe.
Monday, February 8, 2016
Drug shortages are an increasing worldwide problem that cause numerous difficulties for prescribers, pharmacists, patients, and federal regulators.
Friday, January 22, 2016
For all local requests Fagron creates a customized solution for your business challenge or opportunity
Wednesday, January 6, 2016
The results of two studies recently published include data for 20 commonly used API’s from different pharmaceutical classes
Tuesday, December 22, 2015
Seasons Greetings. In warm appreciation of our association during the past year, we extend our very best wishes for a blissful holiday season.
Wednesday, November 25, 2015
A new article has recently been published in the high-impact Journal of Pharmaceutical and Biomedical Analysis
Tuesday, November 10, 2015
Pentravan® has demonstrated to be an effective vehicle for the administration of hormones via the vaginal mucosa.
Monday, October 26, 2015
For patients that require non-standard doses, experience swallowing difficulties or receive medication via enteral feeding tubes, compounding oral liquid dosage forms is common and important pharmacy practice.
Monday, August 31, 2015
Fagron is proud to welcome the pharmaceutical company AnazaoHealth Corporation into the Fagron Family...
Monday, July 20, 2015
Fagron Academy offers comprehensive practical and lecture-based pharmacy compounding education courses for prescribers and pharmacists.
Monday, July 13, 2015
Fagron North America will open one of the largest 503B human drug outsourcing facilities in the U.S. in November...
Friday, April 10, 2015
Excipients are essential ingredients of almost any dermatological product and required to assure numerous properties of the final preparation, such as...
Friday, February 6, 2015
Sign up for our ‘Meet Fagron’ inhouse day on 12 May and discover what it means to work at a global R&D scientific pharmaceutical company.
Wednesday, October 15, 2014
Vi aspettiamo a Farmadays, allo stand n. 98, con le nostre proposte innovative per la galenica
Thursday, September 25, 2014
On 25 September the world pays attention to the role of the pharmacist in improving health in every corner of the world. This years’ theme is:
Friday, September 19, 2014
Fagron Advanced Derma is a total solution for the treatment of dermatological diseases and conditions and now includes a range of eleven skin-friendly vehicles for different skin types and areas.
Monday, August 18, 2014
There is an increasing interest for Pentravan® transdermal cream in scientific literature. A new publication in the most recent edition of the International Journal of Pharmaceutical Compounding concludes that human female sexual hormones incorporated in
Tuesday, July 8, 2014
Fagron Advanced Derma has been introduced in the first half of 2014. This innovative concept is already being used by dermatologists on three continents in their treatment plans.
Fagron Advanced Derma
Wednesday, May 28, 2014
Over 200 unique compounding instructions for more than 120 different active pharmaceutical ingredients (APIs) in Fagron’s global Advanced Derma and SyrSpend® SF bases have been uploaded to the Compounding Matters database.
Friday, March 28, 2014
A unique combination of the CapsiCards® Machine and the CapsiCards®.The total solution for easy and efficient capsule filling.
Wednesday, March 26, 2014
Do you want your ticket to a successful international career in an exciting fast-growing company?
Tuesday, January 7, 2014
Have you always been curious to see and hear what Fagron is all about?
Thursday, January 2, 2014
Fagron has created a revolutionary standard for advanced, individualised dermatological therapy and care.
Thursday, November 7, 2013
Innovative software solutions for pharmaceutical compounding, ready to be launched globally
Wednesday, June 19, 2013
Fagron is ready for compliancy with the Falsified Medicines Directive (2011/62/EU).
Thursday, April 25, 2013
Fagron creates a strong and nation-wide U.S. coverage, immediately delivering extra value to customers
Tuesday, April 9, 2013
In March 2013, Fagron entered into a partnership with NAFA Medical in Saudi Arabia for the purpose of introducing Fagron’s products and concepts onto the Saudi market
Thursday, December 20, 2012
Fagron announces today that it has signed an agreement to acquire B&B Pharmaceuticals
Tuesday, November 13, 2012
Fagron strengthens market leadership with acquisitions in Brazil, Colombia and Scandinavia
Tuesday, June 19, 2012
Pentravan® (penetration enhanced vanishing cream) is a transdermal delivery system for drugs (active pharmaceutical ingredients; APIs) and is intended for use as a cream base for pharmaceutical compounding.
Monday, January 23, 2012
Fagron founded Fagron Academy in 2011.
Tuesday, December 27, 2011
Fagron Group announces today that it has signed an agreement for the acquisition of Polish company Pharma Cosmetic, a leading supplier of pharmaceutical raw materials for compounding pharmacies in Poland.
Sunday, December 11, 2011
Fagron Group announces today that it has signed an agreement for the acquisition of the Brazilian Pharma Nostra, a leading supplier of raw materials for pharmaceutical compounding to pharmacies in Brazil.
Friday, September 2, 2011
This concept, developed in Belgium, will be introduced in other European countries during 2012.
Thursday, September 1, 2011
After a study of the Argentinean market, Fagron Group decided to start a greenfield operation in Buenos Aires.
Friday, July 8, 2011
Fagron announces today that it has signed an agreement for the acquisition of the Dutch Pharma Cosmetic, a compounding pharmacy that specializes in preparing tailor-made aseptic and high risk compounded products for individual patients.
Monday, December 20, 2010
Fagron secures number 2 position in largest compounding market in the world.
Friday, June 4, 2010
Fagron Group announces today that Gallipot has changed its name to Fagron US, officially ending the transition period that started when Fagron Group acquired the former Gallipot in May 2010.
Monday, May 10, 2010
Gallipot is the perfect platform to launch the Fagron strategy in the US
Wednesday, October 7, 2009
The US Food and Drug Administration (FDA) has approved that, in the event of a shortage of Tamiflu®1/Oseltamivir oral suspension for children, pharmacists should revert to emergency compounding, using Ora-Sweet SF® or Humco Cherry Syrup®.
Monday, March 2, 2009
Fagron’s aim is to offer the most innovative and service-oriented services.
Monday, December 8, 2008
Following the success of medicinal cannabis in the Netherlands a number of other countries have shown an interest.
Thursday, July 10, 2008
Fagron expands into Scandinavia
Thursday, April 24, 2008
Fagron to expand into central and Eastern Europe